Biologics in FDA’s 2025 Approvals: Implications for Future CMC Strategies
FDA’s 2025 approvals show biologics growing more complex. Learn why next-gen modalities demand stronger analytics, process design, and integrated CMC strategies.
FDA’s 2025 approvals show biologics growing more complex. Learn why next-gen modalities demand stronger analytics, process design, and integrated CMC strategies.
APC & VLE founders Mark Barrett & Brian Glennon, receive Pharma Leader award for their innovative global centre of excellence in process dev & manufacturing.
Learn more about Nobel-prize winner Barry Sharpless and his impact on modern chemistry.